Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) Study

Active, not recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Epilepsy

Interventions

OTHER

ASM as adjunctive therapy

ASM approved as adjunctive therapy

Trial Locations (1)

"Fondazione IRCCS Istituto Neurologico Carlo Besta U.O. Epilettologia Clinica e Sperimentale - Centro di Medicina del Sonno", Milan